TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31286115

Group type: EXPERIMENTAL
Intervention: Equia Fil/Equia Coat
Number of subjects: 34

Group type: COMPARATOR
Intervention: Fuji IX GP Fast/Fuji Coat LC
Number of subjects: 34
Study: 29037162

Group type: EXPERIMENTAL
Intervention: Progressive aerobic- and resistance-training program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gentle movement control group
Number of subjects: 50
Study: 27473921

Group type: EXPERIMENTAL
Intervention: Collagenase treatment
Number of subjects: 140

Group type: COMPARATOR
Intervention: Needle fasciotomy
Number of subjects: 140
Study: 24680230

Group type: EXPERIMENTAL
Intervention: Written emotional disclosure with response training (n=79)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Written emotional disclosure without response training
Number of subjects: 246

Group type: COMPARATOR
Intervention: Neutral writing (n=133)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Response training
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: No training
Number of subjects: 246
Study: 22980549

Group type: EXPERIMENTAL
Intervention: Software
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Piko/Software
Number of subjects: 1103

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Piko
Number of subjects: 1103
Study: 18274881

Group type: EXPERIMENTAL
Intervention: I-QoL
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: SSI
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: EQ-5D
Number of subjects: 174
Study: 15787022

Group type: EXPERIMENTAL
Intervention: Simulation strategy (two simulation sessions: normal labor and physiological jaundice)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual lectures (control group)
Number of subjects: 36
Study: 12622744

Group type: EXPERIMENTAL
Intervention: Roasted hazelnuts (140°C, 40 min)
Number of subjects: 17
Study: 11143848

Group type: EXPERIMENTAL
Intervention: Patients with coronary artery disease
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Patients with very high lipoprotein (a) levels (> 40 mg/dl)
Number of subjects: 127
Study: 9002327

Group type: COMPARATOR
Intervention: Standard ORS (glucose 20 g/l, osmolarity 311 mmol/l)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Reduced-osmolarity maltodextrin-based ORS (MD 50 g/l, osmolarity 227 mmol/l)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High total stool output (> 300 g/kg)
Number of subjects: 90
Study: 1621021

Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6711776

Group type: EXPERIMENTAL
Intervention: 2 mg morphine hydrochloride bolus followed by continuous morphine infusion at 0.16 mg/hour
Number of subjects: 16

Group type: COMPARATOR
Intervention: Epidural infusion of 2.3 +/- 0.6 mg morphine hydrochloride until the end of the operation
Number of subjects: 16
Study: 30611229

Group type: EXPERIMENTAL
Intervention: Decompression alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decompression with instrumental fusion
Number of subjects: 0
Study: 29866397

Group type: EXPERIMENTAL
Intervention: Plain radiographs
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: CT scans
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both radiographs and CT scans viewed together
Number of subjects: 116
Study: 27526979

Group type: EXPERIMENTAL
Intervention: Rifampicin 750 mg orally
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rifampicin 900 mg orally
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rifampicin 600 mg intravenously (i.v.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rifampicin (all doses)
Number of subjects: 30
Study: 25462535

Group type: EXPERIMENTAL
Intervention: Raltegravir intensification in PI-treated individuals
Number of subjects: 67

Group type: COMPARATOR
Intervention: Raltegravir intensification
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intensification)
Number of subjects: 67
Study: 22526948

Group type: EXPERIMENTAL
Intervention: Trunk flexion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trunk extension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trunk involvement (flexion or extension)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trunk flexion and extension
Number of subjects: 0
Study: 20107946

Group type: EXPERIMENTAL
Intervention: Laparoscopic colorectal cancer resection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study: 20003828

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10mg daily
Number of subjects: 63

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 63
Study: 15836983

Group type: EXPERIMENTAL
Intervention: Cold CRPS 1 patients (n=13)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Warm CRPS 1 patients (n=34)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both diagnostic subgroups
Number of subjects: 47
Study: 12592250

Group type: EXPERIMENTAL
Intervention: Progesterone (100 mg) administered daily by vaginal suppository
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo administered daily by vaginal suppository
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Progesterone group
Number of subjects: 142
Study: 10680454

Group type: EXPERIMENTAL
Intervention: Beta-lactam antibiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8740861

Group type: EXPERIMENTAL
Intervention: Anthraxin skin test
Number of subjects: 0
Study: 1684273

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg once daily for seven days
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 7067924

Group type: EXPERIMENTAL
Intervention: Repeat action tablet (60 mg d-pseudoephedrine sulfate in the coat and 60 mg d-pseudoephedrine sulfate in the core)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional tablets (two 60 mg tablets, one at 0 hour and one at 6 hours)
Number of subjects: 0
Study: 28826274

Group type: EXPERIMENTAL
Intervention: 12-week running intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 42
Study: 27655522

Group type: EXPERIMENTAL
Intervention: Normocis400® (combined nutraceutical containing 400 μg folate-6-5-methyltetrahydrofolate, 3 mg vitamin B6, 5 μg vitamin B12, 2.4 mg vitamin B2, 12.5 mg zinc and 250 mg betaine) once daily for two months
Number of subjects: 104

Group type: COMPARATOR
Intervention: Highly dosed folic acid (5 mg/day) (control group)
Number of subjects: 104
Study: 24563517

Group type: EXPERIMENTAL
Intervention: Toenail selenium levels
Number of subjects: 1865

Group type: EXPERIMENTAL
Intervention: SEPP1 rs7579 genetic variant
Number of subjects: 1865

Group type: EXPERIMENTAL
Intervention: GPX1 rs17650792 genetic variant
Number of subjects: 1865

Group type: EXPERIMENTAL
Intervention: GPX1 rs1800668 genetic variant
Number of subjects: 1865
Study: 22278284

Group type: EXPERIMENTAL
Intervention: Mobile phone depression prevention intervention (2 messages/day for 9 weeks)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Mobile phone depression prevention intervention
Number of subjects: 855

Group type: COMPARATOR
Intervention: Attention control program
Number of subjects: 855
Study: 20204538

Group type: COMPARATOR
Intervention: Model A = traditional HIV counseling and testing
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Model B = nurse-initiated routine screening with traditional HIV testing and counseling
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Model C = nurse-initiated routine screening with rapid HIV testing and streamlined counseling
Number of subjects: 251
Study: 18568182

Group type: EXPERIMENTAL
Intervention: Extended-release dipyridamole (ER-DP) plus aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 15963617

Group type: EXPERIMENTAL
Intervention: Cranio-cervical flexion action training session
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Whiplash group
Number of subjects: 23
Study: 12949809

Group type: EXPERIMENTAL
Intervention: Tobacco chewing
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Tobacco chewing frequency
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Tobacco chewing duration
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Alcohol drinking
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 115
Study: 10804488

Group type: EXPERIMENTAL
Intervention: Clinical estimates
Number of subjects: 758

Group type: COMPARATOR
Intervention: Sonographic estimates
Number of subjects: 758
Study: 8891854

Group type: EXPERIMENTAL
Intervention: Conventional plus L-dopa treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 20
Study: 1828840

Group type: EXPERIMENTAL
Intervention: Halofantrine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 122
Study: 6517125

Group type: EXPERIMENTAL
Intervention: Thermal disinfection regimen for the lens on the right eye
Number of subjects: 8

Group type: COMPARATOR
Intervention: Chemical disinfection regimen for the lens on the left eye
Number of subjects: 8
Study: 30799475

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SBU) in self-etch mode (SE) before thermocycling (TC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Prime & Bond Elect (PBE) in self-etch mode (SE) before thermocycling (TC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: All‐Bond Universal (ABU) in self-etch mode (SE) before thermocycling (TC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: iBond Universal (IBU) in self-etch mode (SE) before thermocycling (TC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SBU) in etch-and-rinse mode (ER) before thermocycling (TC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Prime & Bond Elect (PBE) in etch-and-rinse mode (ER) before thermocycling (TC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: All‐Bond Universal (ABU) in etch-and-rinse mode (ER) before thermocycling (TC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: iBond Universal (IBU) in etch-and-rinse mode (ER) before thermocycling (TC)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Optibond FL (OFL) as etch-and-rinse control
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: iBond Universal (IBU) in self-etch mode (SE) after thermocycling (TC)
Number of subjects: 360
Study: 30935071

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (arts/crafts activities)
Number of subjects: 66
Study: 28750109

Group type: EXPERIMENTAL
Intervention: Zirconia-ceramic (ZC) fixed dental prostheses
Number of subjects: 58

Group type: COMPARATOR
Intervention: Metal-ceramic (MC) fixed dental prostheses
Number of subjects: 58
Study: 26213789

Group type: EXPERIMENTAL
Intervention: Structured Approach Therapy (SAT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: PTSD Family Education (PFE)
Number of subjects: 57
Study: 23228924

Group type: EXPERIMENTAL
Intervention: Anthracycline treatment
Number of subjects: 42
Study: 21971213

Group type: EXPERIMENTAL
Intervention: Capsaicin 15 mg (Anesiva 4975) instillation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo vehicle instillation
Number of subjects: 14
Study: 18273636

Group type: EXPERIMENTAL
Intervention: Fast-track treatment arm
Number of subjects: 82

Group type: COMPARATOR
Intervention: Traditional treatment arm
Number of subjects: 82
Study: 16603986

Group type: EXPERIMENTAL
Intervention: Early, culturally sensitive, post-Caesarean breastfeeding guidance and education by trained professionals (n=306)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Standard hospital care (n=264)
Number of subjects: 570
Study: 12924536

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10846912

Group type: EXPERIMENTAL
Intervention: Thiopental 5 mg/kg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Etomidate 0.3 mg/kg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Propofol 3 mg/kg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Midazolam 0.2 mg/kg
Number of subjects: 96
Study: 9442546

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fluvoxamine and Clomipramine
Number of subjects: 18
Study: 8448974

Group type: EXPERIMENTAL
Intervention: Intravenous [14C]omeprazole 20mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral solution [14C]omeprazole 40mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Young healthy volunteers (control group)
Number of subjects: 8
Study: 2431021

Group type: EXPERIMENTAL
Intervention: Theophylline (8 to 21 micrograms/ml)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31603033

Group type: EXPERIMENTAL
Intervention: Time Regime 1 (TR1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time Regime 2 (TR2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 0
Study: 31754687

Group type: EXPERIMENTAL
Intervention: High-protein (HP) diet (25:45:30% energy from protein:carbohydrate:fat)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Moderate-protein (MP) diet (15:55:30% energy from protein:carbohydrate:fat)
Number of subjects: 38
Study: 29886466

Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional two-dimensional radiotherapy
Number of subjects: 200
Study: 27501629

Group type: EXPERIMENTAL
Intervention: Nurse practitioner‐facilitated chronic kidney disease group visit (GV) model
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual nephrology care
Number of subjects: 30
Study: 1385147

Group type: EXPERIMENTAL
Intervention: Hormone therapy for BPH
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Drug trial
Number of subjects: 66
Study: 22809684

Group type: EXPERIMENTAL
Intervention: Long acting injection (RLAI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral risperidone (RisO)
Number of subjects: 22
Study: 20406256

Group type: EXPERIMENTAL
Intervention: Goldmann tonometer
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-contact tonometers (Topcon CT80 and Keeler Pulsair EasyEye)
Number of subjects: 120
Study: 18712214

Group type: EXPERIMENTAL
Intervention: Intensified Training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal Training
Number of subjects: 20
Study: 15964686

Group type: EXPERIMENTAL
Intervention: Graded exposure in vivo (GEXP)
Number of subjects: 8
Study: 12690999

Group type: EXPERIMENTAL
Intervention: Lavender essential oil
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Rosemary essential oil
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control (no odor)
Number of subjects: 144
Study: 10496259

Group type: EXPERIMENTAL
Intervention: lamotrigine
Number of subjects: 64

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 64
Study: 9114899

Group type: EXPERIMENTAL
Intervention: Feedback from standardized patients (SPs)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Feedback from faculty
Number of subjects: 120
Study: 1813168

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) and clomiphene
Number of subjects: 149

Group type: COMPARATOR
Intervention: Clomiphene
Number of subjects: 149

Group type: COMPARATOR
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 149
Study: 6994779

Group type: EXPERIMENTAL
Intervention: Guanfacine 3.5 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methyldopa 1.2 g daily
Number of subjects: 20
Study: 30866859

Group type: EXPERIMENTAL
Intervention: Intervention with print educational materials and Fitbit Flex™ and daily text messages
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control with print educational materials alone
Number of subjects: 42
Study: 28851337

Group type: EXPERIMENTAL
Intervention: Education module only
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Email prompt only
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Email prompt and education module
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (no education module and no email prompt)
Number of subjects: 189
Study: 26482019

Group type: EXPERIMENTAL
Intervention: Computerised WINGS
Number of subjects: 191

Group type: COMPARATOR
Intervention: Case Manager WINGS
Number of subjects: 191
Study: 23564001

Group type: EXPERIMENTAL
Intervention: Radiographic Union Score for Hip (RUSH)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Subjective assessment of overall healing
Number of subjects: 150
Study: 17625632

Group type: EXPERIMENTAL
Intervention: Mental training
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 41
Study: 16036033

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRT alone or in conjunction with an ICD
Number of subjects: 0
Study: 11059947

Group type: EXPERIMENTAL
Intervention: HFA-MDI (fenoterol hydrobromide, 100 microg, two puffs, four times a day)
Number of subjects: 290

Group type: COMPARATOR
Intervention: CFC-MDI (fenoterol hydrobromide, 100 microg, two puffs, four times a day)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: HFA-MDI
Number of subjects: 290

Group type: COMPARATOR
Intervention: CFC-MDI
Number of subjects: 290
Study: 9292565

Group type: EXPERIMENTAL
Intervention: High-flux polysulfone membrane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cellulose membrane
Number of subjects: 20
Study: 8039761

Group type: EXPERIMENTAL
Intervention: Erwinia L-asparaginase
Number of subjects: 10

Group type: COMPARATOR
Intervention: E. Coli L-asparaginase
Number of subjects: 10
Study: 3090512

Group type: EXPERIMENTAL
Intervention: Human milk (n = 354)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: Formula (n = 320)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Cow's milk (n = 146)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: Formula or human milk (younger subjects)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: All milk feeding groups (40 infants 8 to 12 months)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: All milk feeding groups (792 stool smears)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: All milk feeding groups (705 stool smears)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: All infants
Number of subjects: 820
Study: 31828137

Group type: EXPERIMENTAL
Intervention: Intensified regimen (higher dosage of cefoxitin and linezolid, along with conventional drugs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional regimen (including macrolide and moxifloxacin, initial 12-week course of low-dose cefoxitin and amikacin)
Number of subjects: 50
Study: 30574354

Group type: EXPERIMENTAL
Intervention: STEPWISE intervention (lifestyle intervention for weight management)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: STEPWISE intervention
Number of subjects: 0
Study: 26867764

Group type: EXPERIMENTAL
Intervention: Epirubicin (90 mg/m2 iv q 3 weeks)
Number of subjects: 25
Study: 24564266

Group type: EXPERIMENTAL
Intervention: Remifentanil (50 μg/ml) at an infusion rate of 0.07 μg/kg/min with bolus doses of 0.25 μg/kg and a 5‐min lockout time
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fentanyl (50 μg/ml) at an infusion rate of 0.1 μg/kg/min with bolus doses of 1 μg/kg and a 5‐min lockout time
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both interventions (Remifentanil and Fentanyl)
Number of subjects: 50
Study: 22812672

Group type: EXPERIMENTAL
Intervention: IV tigecycline (100 mg, then 50 mg q12h)
Number of subjects: 294

Group type: COMPARATOR
Intervention: IV levofloxacin (500 mg q24h)
Number of subjects: 294
Study: 19954405

Group type: EXPERIMENTAL
Intervention: Oral sustained release mucoadhesive nystatin tablets
Number of subjects: 12

Group type: COMPARATOR
Intervention: Commercial oral nystatin suspension
Number of subjects: 12
Study: 17998981

Group type: EXPERIMENTAL
Intervention: Diabetes certificate program (elective course)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no elective course)
Number of subjects: 37
Study: 16353657

Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling intervention
Number of subjects: 430

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 430
Study: 12216559

Group type: EXPERIMENTAL
Intervention: Conventional glass ionomer (GI)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Resin modified glass ionomer (RMGI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Resin composite (C)
Number of subjects: 45
Study: 10221490

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 83

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 83
Study: 7531132

Group type: EXPERIMENTAL
Intervention: 4 brachytherapies with a dose of 3.8 Gy on a weekly basis (Group 1)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 2 treatments with 7.2 Gy at a 3-week interval (Group 2)
Number of subjects: 93
Study: 2145872

Group type: EXPERIMENTAL
Intervention: Alpha‐h‐ANP infusion (50 ng/kg/min over 1 h after a bolus of 50 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 8
Study: 340331

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31121285

Group type: EXPERIMENTAL
Intervention: Real tDCS over the right inferior frontal gyrus
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 57
Study: 28364853

Group type: EXPERIMENTAL
Intervention: Affirmative writing interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25675060

Group type: EXPERIMENTAL
Intervention: Full-endoscopic interlaminar technique (FI)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Microsurgical laminotomy technique (MI)
Number of subjects: 135
Study: 23651756

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20